Rare inborn errors of metabolism with movement disorders: a case study to evaluate the impact upon quality of life and adaptive functioning

Orphanet Journal of Rare Diseases

Tom J de Koning⁵  Marina AJ Tijssen³  Deborah A Sival³  Bart Post¹  Annet M Bosch²  Maria Fiorella Contarino⁴  Kathryn J Peall³  Anouk Kuiper³  Hendriekje Eggink³ 

[1] Department of Neurology, Radboud University Nijmegen Medical Centre, Geert Grooteplein-Zuid 10, Nijmegen, 6525, GA, The Netherlands;Department of Paediatrics, University of Amsterdam, Academic Medical Centre, Meibergdreef 9, Amsterdam, 1105, AZ, The Netherlands;Department of Neurology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9700, RB, The Netherlands;Department of Neurology, Haga Ziekenhuis Teaching Hospital, Leyweg 275, The Hague, 2545, CH, The Netherlands;Department of Genetics, University Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9700, RB, The Netherlands

关键词: Ataxia;    Myoclonus;    Dystonia;    Adaptive functioning;    Quality of life;    Movement disorders;    Inborn errors of metabolism;   

Others  :  1138792
DOI  :  10.1186/s13023-014-0177-6

 received in 2014-06-17, accepted in 2014-10-31,  发布年份 2014

【 摘 要 】

Background

Inborn errors of metabolism (IEM) form an important cause of movement disorders in children. The impact of metabolic diseases and concordant movement disorders upon children’s health-related quality of life (HRQOL) and its physical and psychosocial domains of functioning has never been investigated. We therefore conducted a case study on the HRQOL and development of adaptive functioning in children with an IEM and a movement disorder.

Methods

Children with co-existent IEM and movement disorders were recruited from paediatric outpatient clinics. We systematically collected clinical data and videotaped examinations. The movement disorders were diagnosed by a panel of specialists. The Pediatric Quality of Life Inventory 4.0 and the Vineland Adaptive Behavior Scale were used to assess the HRQOL and adaptive functioning, respectively.

Results

We recruited 24 children (10 boys, mean age 7y 5 m). Six types of movement disorders were recognised by the expert panel, most frequently dystonia (16/24), myoclonus (7/24) and ataxia (6/24). Mean HRQOL (49.63, SD 21.78) was significantly lower than for other chronic disorders in childhood (e.g. malignancy, diabetes mellitus, rheumatic disease, psychiatric disorders; p <0.001) and tended to diminish with the severity of the movement disorder. The majority of participants had delayed adaptive functioning, most evident in their activities of daily living (51.92%, SD 27.34). Delay in adaptive functioning had a significant impact upon HRQOL (p = 0.018).

Conclusions

A broad spectrum of movement disorders was seen in patients with IEM, although only five were receiving treatment. The overall HRQOL in this population is significantly reduced. Delay in adaptive functioning, most frequently seen in relation to activities of daily living, and the severity of the movement disorder contribute to this lower HRQOL. We plead for a greater awareness of movement disorders and that specialists should be asked to diagnose and treat these wherever possible.

【 授权许可】

   
2014 Eggink et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]García-Cazorla A, Wolf NI, Serrano M, Pérez-Duenas B, Pineda M, Campistol J, Fernández-Alvarez E, Colomer J, DiMauro S, Hoffman GF: Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis 2009, 32:618-629.
• [2]Gouider-Khouja N, Kraoua I, Benrhouma H, Fraj N, Rouissi A: Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol 2010, 14:304-307.
• [3]Delgado MR, Albright AL: Movement disorders in children: definitions, classifications, and grading systems. J Child Neurol 2003, 18:S1-S8.
• [4]Varni JW, Burwinkle TM, Lane MM: Health-related quality of life measurement in pediatric clinical practice: an appraisal and precept for future research and application. Health Qual Life Outcomes 2005, 3(34):1-9.
• [5]Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK: Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 2004, 7:79-92.
• [6]Leidy NK, Revicki DA, Geneste B: Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999, 2(2):113-127.
• [7]Varni JW, Limbers CA, Burwinkle TM: Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 generic core scales. Health Qual Life Outcomes 2007, 5:43. BioMed Central Full Text
• [8]Thimm E, Schmidt LE, Heldt K, Spiekerkoetter U: Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents. J Inherit Metab Dis 2013, 36(5):767-772.
• [9]Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA: The course of life and quality of life in early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 2007, 30:29-34.
• [10]Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF: Living with classical galactosemia, health related quality of life consequences. Pediatrics 2004, 113(5):e423-e428.
• [11]Raluy-Callado M, Wen-Chung C, Whiteman DAH, Fang J, Wiklund I: The impact of Hunter syndrome (mucopolysaccharidosis type II) on health-related quality of life. Orphanet J Rare Dis 2013, 8:101. BioMed Central Full Text
• [12]Cleary MA, Green A: Developmental delay: when to suspect and how to investigate for an inborn error of metabolism. Arch Dis Child 2005, 90:1128-1132.
• [13]Mental Retardation: Definition, Classification, and Systems of Support, 10th edn. American Association on Mental Retardation, Washington, DC; 2002.
• [14]Bastiaansen D, Koot HM, Bongers IL, Varni JW, Verhulst FC: Measuring quality of life in children referred for psychiatric problems: psychometric properties of the PedsQL 4.0 generic core scales. Qual Lif Res 2004, 13(2):489-495.
• [15]Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL: The PedsQL in type 1 and type 2 diabetes: reliability and validity of the pediatric quality of life inventory generic core scales and type 1 diabetes module. Diabetes Care 2003, 26(3):631-637.
• [16]Varni JW, Burwinkle TM, Szer IS: The PedsQL multidimensional fatigue scale in pediatric rheumatology: reliability and validity. J Rheumatol 2004, 31:2494-2500.
• [17]Bastiaansen D, Koot HM, Ferdinand RF, Verhulst FC: Quality of life in children with psychiatric disorders: self, parent and clinician report. J Am Acad Child Adolesc Psychiatry 2004, 43:221-230.
• [18]Varni JW, Burwinkle TM, Berrin SJ, Sherman SA, Artavia K, Malcarna VL, Chambers HG: The PedsQL in pediatric cerebral palsy: reliability, validity and sensitivity of generic core scales and cerebral palsy module. Dev Med Child Neurol 2006, 48(6):442-449.
• [19]de Bildt AA, Kraijer DW, Sytema S, Minderaa R: The psychometric properties of the vineland adaptive behavior scales in children and adolescents with mental retardation. J Autism Dev Disord 2005, 35:63-74.
• [20]Cans C, Guillem P: Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol 2002, 44:633-640.
• [21]Sedel F, Saudubray JM, Roze E, Agid Y, Vidailhet M: Movement disorders and inborn errors of metabolism in adults: a diagnostic approach. J Inherit Metab Dis 2008, 31:308-318.
• [22]Eiser C, Morse R: Can parents rate their child’s health-related quality of life? results of a systematic review. Qual Lif Res 2001, 10(4):347-357.